Q
GILD icon

QVR’s Gilead Sciences GILD Stock Holding History

QVR’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,400
Closed -$334K – 55
2026
Q1 		$334K Buy
+2,400
New +$336K 0.01% 109
2023
Q1 		– Sell
-3,000
Closed -$258K – 72
2022
Q4 		$258K Sell
3,000
-24,000
-89% -$1.9M 0.03% 92
2022
Q3 		$1.67M Buy
27,000
+5,800
+27% +$366K 0.14% 125
2022
Q2 		$1.31M Sell
21,200
-28,400
-57% -$1.76M 0.1% 153
2022
Q1 		$2.95M Buy
+49,600
New +$3.17M 0.11% 180
2021
Q4 		– Sell
-29,700
Closed -$2.08M – 126
2021
Q3 		$2.08M Buy
29,700
+21,800
+276% +$1.53M 0.14% 118
2021
Q2 		$545K Buy
7,900
+4,200
+114% +$280K 0.06% 171
2021
Q1 		$239K Buy
+3,700
New +$239K 0.02% 115

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

QVR's GILD Position: Q2 2026 in Review

QVR sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 22 shares — an estimated $3.07K sold.

QVR first reported a position in GILD in Q1 2021 and held it in 8 quarters. The position peaked at $254K in Q4 2025. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • QVR reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • QVR sold 22 Gilead Sciences shares in Q2 2026, an estimated $3.07K.
  • QVR first reported a position in Gilead Sciences in Q1 2021 and held it in 8 quarters.
  • QVR's Gilead Sciences position peaked at $254K in Q4 2025.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.